A graduate of the Harvard Business School, Thompson Dean is the CEO and cofounder of Avista Capital Partners, a private equity firm with a focus on the healthcare industry. Under Thompson Dean’s leadership, Avista Capital Partners has developed a deep understanding of trends within the healthcare industry, guiding the firm to a sound investment strategy in pharmaceuticals, medical devices, distribution, and consumer-driven healthcare. Recently, Osmotica Pharmaceutical received FDA approval for Osmolex ER, a drug used to treat Parkinson’s disease.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly